Literature DB >> 21629175

Protection of bile ducts in liver transplantation: looking beyond ischemia.

Sanna Op den Dries1, Michael E Sutton, Ton Lisman, Robert J Porte.   

Abstract

Biliary complications, especially nonanastomotic biliary strictures (NAS), are a major cause of morbidity after orthotopic liver transplantation. Of all donor and recipient characteristics known to increase the risk of developing NAS, the role of prolonged ischemia times is most extensively described in the literature. However, there is increasing evidence that several other, non-ischemia-related factors play a critical role in the pathogenesis of NAS as well. The clinical presentation of NAS may vary considerably among liver transplant recipients, including large variations in time of occurrence, and in location and severity of the strictures. Additional underlying causes such as bile salt toxicity and immune-mediated injury are believed to explain the wide spectrum of biliary strictures after orthotopic liver transplantation. Current and emerging insight in the pathogenesis of NAS and potential targets to reduce biliary injury and preserve bile ducts are discussed in this overview.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21629175     DOI: 10.1097/TP.0b013e318223a384

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  30 in total

1.  SIMPLE MACHINE PERFUSION SIGNIFICANTLY ENHANCES HEPATOCYTE YIELDS OF ISCHEMIC AND FRESH RAT LIVERS.

Authors:  Maria-Louisa Izamis; Candice Calhoun; Basak E Uygun; Maria Angela Guzzardi; Gavrielle Price; Martha Luitje; Nima Saeidi; Martin L Yarmush; Korkut Uygun
Journal:  Cell Med       Date:  2013

2.  Intrahepatic Delivery of Pegylated Catalase Is Protective in a Rat Ischemia/Reperfusion Injury Model.

Authors:  Clifford Akateh; Eliza W Beal; Jung-Lye Kim; Brenda F Reader; Katelyn Maynard; Jay L Zweier; Bryan A Whitson; Sylvester M Black
Journal:  J Surg Res       Date:  2019-02-13       Impact factor: 2.192

Review 3.  Benign Biliary Strictures.

Authors:  Ashley Altman; Steven M Zangan
Journal:  Semin Intervent Radiol       Date:  2016-12       Impact factor: 1.513

4.  Ex Situ Normothermic Machine Perfusion of Donor Livers.

Authors:  Negin Karimian; Alix P M Matton; Andrie C Westerkamp; Laura C Burlage; Sanna Op den Dries; Henri G D Leuvenink; Ton Lisman; Korkut Uygun; James F Markmann; Robert J Porte
Journal:  J Vis Exp       Date:  2015-05-26       Impact factor: 1.355

5.  Biliary epithelial cells proliferate during oxygenated ex situ liver culture.

Authors:  Congwen Bian; Yiqi Du; Rui Ding; Jun Huang; Yan Dai; Sujin Bao; Lijuan Zhao; Hefang Shen; Jing Dong; Jianjian Xu; Qiru Xiong; Lili Xu
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

Review 6.  Percutaneous Management of Benign Biliary Strictures.

Authors:  Adam Fang; Il Kyoon Kim; Ifechi Ukeh; Vahid Etezadi; Hyun S Kim
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

Review 7.  Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation.

Authors:  Moustafa Mabrouk Mourad; Abdullah Algarni; Christos Liossis; Simon R Bramhall
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

8.  Histological examination and evaluation of donor bile ducts received during orthotopic liver transplantation--a morphological clue to ischemic-type biliary lesion?

Authors:  Torsten Hansen; David Hollemann; Michael B Pitton; Michael Heise; Maria Hoppe-Lotichius; Marcus Schuchmann; C James Kirkpatrick; Gerd Otto
Journal:  Virchows Arch       Date:  2012-05-17       Impact factor: 4.064

9.  Effects of warm ischemia time on biliary injury in rat liver transplantation.

Authors:  Xin-Hua Zhu; Jun-Ping Pan; Ya-Fu Wu; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

10.  Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation.

Authors:  Raffaele Cursio; Jean Gugenheim
Journal:  J Transplant       Date:  2012-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.